ByteDance Is Planning A $23 Billion Investment In AI Infrastructure, And US Regulators Approved Novo Nordisk’s Once-A-Day Wegovy Pill

from The Finimize Daily Brief · host Finimize

ByteDance is planning a $23 billion investment in AI infrastructure – but it’ll take more than that to match Big Tech – US regulators approved Novo Nordisk’s once-a-day Wegovy pill, handing the Danish drugmaker an early edge over rival Eli Lilly.Today’s stories:ByteDance Is Making A $23 Billion Bid, Eager To Take A Chunk Out Of Big Tech’s AI LeadUS Regulators Approved Novo Nordisk’s Weight-Loss PillTry Finimize Pro

Episode metadata supplied by the publisher feed · Published Dec 24, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

ByteDance Is Planning A $23 Billion Investment In AI Infrastructure, And US Regulators Approved Novo Nordisk’s Once-A-Day Wegovy Pill

0:00 5:46

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Finimize Daily Brief?

This episode is 5 minutes long.

When was this The Finimize Daily Brief episode published?

This episode was published on December 24, 2025.

Can I download this The Finimize Daily Brief episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!